Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

GreeceBack to Greece

Clinical trials in Tripoli

2 clinical trials in Tripoli, Greece. Every trial is listed in the EU Clinical Trials Register and updated daily.

Tripoli at a glance
2
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

2 trials in Tripoli

Open in trial search

Major depression

Recruiting
Investigational
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:LY3537031
  • Sponsor:Eli Lilly & Co.

Acute myocardial infarction

Not recruiting
Investigational
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S

Other cities in Greece

The busiest research cities in the country

All 50 cities in Greece

Clinical research in Tripoli

What the registry says about research in the country

01 Tripoli
Cardiovascular Disease Research
In Tripoli, investigators are evaluating an innovative anti‑inflammatory antibody to lower the risk of recurrent events after a heart attack. The study compares the new therapy with standard care, aiming to prove that early intervention can reduce major adverse cardiovascular outcomes in patients with type 1 AMI (both STEMI and NSTEMI). Testing monthly subcutaneous dosing of the IL‑6 targeting antibody Measuring reduction in high‑sensitivity C‑reactive protein as a biomarker Assessing safety alongside standard post‑AMI treatment Evaluating impact on 4‑component major adverse cardiovascular events Results could reshape prevention strategies for cardiovascular disease by linking inflammation control directly to event reduction.
Mental Health Research
A parallel trial in the city focuses on improving outcomes for adults with major depressive disorder. Researchers are testing an experimental peptide, added to existing stable medication, to determine whether it offers a superior benefit over placebo. Evaluating dose‑response relationships for the adjunctive treatment Monitoring changes in depressive symptom scales Ensuring safety when combined with standard antidepressants Exploring rapid onset of therapeutic effect Success in this study would provide a new option for patients whose depression remains insufficiently managed by current therapies.
Back to GreeceAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.